Premier Asset Management LLC Altimmune, Inc. Transaction History

Premier Asset Management LLC

  • $0
  • Q1 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$12.71 - $24.31 $706,370 - $1.35 Million
-55,576 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$7.84 - $14.22 $435,715 - $790,290
55,576 New
55,576 $627,000
Q3 2020

Nov 16, 2020
SELL
$9.93 - $33.26 $253,363 - $848,628
-25,515 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$2.9 - $10.71 $73,993 - $273,265
25,515 New
25,515 $273,000

Others Institutions Holding ALT

# of Institutions
186
Shares Held
39.3M
Call Options Held
913K
Put Options Held
743K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $426M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email